MedPath

江苏广承药业有限公司

Ownership
-
Established
2017-10-25
Employees
-
Market Cap
-
Website
www.guangchengyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Pranoprofen Eye Drops

Product Name
普拉洛芬滴眼液
Approval Number
国药准字H20253947
Approval Date
Apr 15, 2025
NMPA

Compound Dextromethorphan Hydrobromide Syrup

Product Name
复方氢溴酸右美沙芬糖浆
Approval Number
国药准字H20193258
Approval Date
Sep 10, 2024
NMPA

Levetiracetam Oral Solution

Product Name
左乙拉西坦口服溶液
Approval Number
国药准字H20244796
Approval Date
Sep 3, 2024
NMPA

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20243341
Approval Date
Mar 12, 2024
NMPA

Moxifloxacin Hydrochloride Eye Drops

Product Name
盐酸莫西沙星滴眼液
Approval Number
国药准字H20234682
Approval Date
Dec 26, 2023
NMPA

Atomoxetine Hydrochloride Oral Solution

Product Name
盐酸托莫西汀口服溶液
Approval Number
国药准字H20234212
Approval Date
Sep 28, 2023
NMPA

Olopatadine Hydrochloride Eye Drops

Product Name
盐酸奥洛他定滴眼液
Approval Number
国药准字H20183349
Approval Date
Jul 13, 2023
NMPA

Desloratadine Syrup

Product Name
地氯雷他定糖浆
Approval Number
国药准字H20183211
Approval Date
Apr 17, 2023
NMPA

Simethicone Emulsion

Product Name
西甲硅油乳剂
Approval Number
国药准字H20173062
Approval Date
Feb 11, 2022
NMPA

Loratadine Syrup

Product Name
氯雷他定糖浆
Approval Number
国药准字H20103533
Approval Date
Jul 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath